Koei Tecmo and Gust have announced a new entry in the mystery solving adventure genre, The Apothecary Diaries: The False Imperial Brother. This title matters to players who follow the Apothecary Maomao series because it expands the franchise onto modern hardware including the Switch 2. The game brings the character's herbal medicine and deduction skills to a broader audience across consoles and PC.
Mystery adventure featuring Maomao arrives on multiple platforms in 2027
The game centers on Maomao as she navigates a complex web of intrigue. Players will craft herbal medicine and utilize cunning deduction to solve the central mysteries. The narrative focuses on uncovering truths behind the Five Mysteries and Five Curses, which are chains of strange phenomena causing chaos.
- Platforms: PlayStation 5, Switch 2, Switch, PC (Steam)
- Release Window: Early 2027
- Developer: Gust
- Publisher: Koei Tecmo
- Co-Publisher: TOHO Games
Koei Tecmo confirmed the game will launch in early 2027. It is available on PlayStation 5, Switch 2, Switch, and PC via Steam. TOHO Games is cooperating on the release alongside the primary developer Gust. This multi-platform approach ensures the game reaches both traditional console players and PC gamers.
The plot involves Maomao investigating conspiracies throughout the rear palace, pleasure district, and streets of the capital. Koei Tecmo stated that players must uncover the truths behind these two chains of strange phenomena. The game targets fans of narrative-driven adventures who enjoy detailed investigation mechanics. We touched on Koei Tecmo TGS 2026 Lineup Reveals in our earlier Koei tecmo coverage.
The Apothecary Diaries: The False Imperial Brother is scheduled for an early 2027 release. It will arrive on PlayStation 5, Switch 2, Switch, and PC. The game is developed by Gust and published by Koei Tecmo with TOHO Games.
Source: Gematsu
